Literature DB >> 19489943

Do neonates with genetic abnormalities have an increased morbidity and mortality following cardiac surgery?

Janet M Simsic1, Karlene Coleman, Kevin O Maher, Angel Cuadrado, Paul M Kirshbom.   

Abstract

INTRODUCTION: Genetic abnormalities occur in approximately 20% of children with congenital heart disease. The purpose of this study was to evaluate the effect of genetic abnormalities on short-term outcomes following neonatal cardiac surgery.
METHODS: Retrospective review of all neonates (n = 609) undergoing cardiac surgery from January 2003 to December 2006. Genetic abnormalities were identified in 93 neonates (15%). Genetic abnormalities identified were 22q11.2 deletion (23), chromosomal abnormalities including various monosomies, trisomies, deletions, duplications, and inversions (17), dysmorphic undefined syndrome without recognized chromosomal abnormality (27), Down syndrome (9), laterality sequences (9), recognixed syndromes and genetic etiology including Mendelian (i.e. Alagille, CHARGE) (8).
RESULTS: Neonates with genetic abnormalities had lower birth weights and were older at time of surgery. There was no difference in operative variables, duration of mechanical ventilation or ICU length of stay between the two groups. There was an increase in total hospital length of stay and postoperative complications in the neonates with genetic abnormalities. Importantly, in hospital mortality was not different.
CONCLUSION: Neonates with genetic abnormalities have a higher risk of postoperative complications and a longer hospital length of stay. However, there is no increase in hospital mortality. This information may aid in patient management decisions and parental counseling. Longer-term studies are needed for understanding the total impact of genetic abnormalities on neonates with congenital heart disease.

Entities:  

Mesh:

Year:  2009        PMID: 19489943     DOI: 10.1111/j.1747-0803.2009.00281.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  11 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database.

Authors:  James C Fudge; Shuang Li; James Jaggers; Sean M O'Brien; Eric D Peterson; Jeffrey P Jacobs; Karl F Welke; Marshall L Jacobs; Jennifer S Li; Sara K Pasquali
Journal:  Pediatrics       Date:  2010-07-12       Impact factor: 7.124

3.  Use of Extracorporeal Membrane Oxygenation and Mortality in Pediatric Cardiac Surgery Patients With Genetic Conditions: A Multicenter Analysis.

Authors:  Jamie M Furlong-Dillard; Venugopal Amula; David K Bailly; Steven B Bleyl; Jacob Wilkes; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

Review 4.  22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Authors:  Carolina Putotto; Flaminia Pugnaloni; Marta Unolt; Stella Maiolo; Matteo Trezzi; Maria Cristina Digilio; Annapaola Cirillo; Giuseppe Limongelli; Bruno Marino; Giulio Calcagni; Paolo Versacci
Journal:  Children (Basel)       Date:  2022-05-25

5.  Current Practice and Utility of Chromosome Microarray Analysis in Infants Undergoing Cardiac Surgery.

Authors:  Jason R Buckley; Minoo N Kavarana; Shahryar M Chowdhury; Mark A Scheurer
Journal:  Congenit Heart Dis       Date:  2014-12-14       Impact factor: 2.007

6.  22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases.

Authors:  Shabnam Peyvandi; Philip J Lupo; Jennifer Garbarini; Stacy Woyciechowski; Sharon Edman; Beverly S Emanuel; Laura E Mitchell; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2013-04-21       Impact factor: 1.655

7.  Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery.

Authors:  Rachel McDonald; Andrew Dodgen; Sunali Goyal; Jeffrey M Gossett; Takeshi Shinkawa; Santosh C Uppu; Carlos Blanco; Xiomara Garcia; Adnan T Bhutta; Michiaki Imamura; Punkaj Gupta
Journal:  Pediatr Cardiol       Date:  2012-08-03       Impact factor: 1.655

8.  Extracorporeal membrane oxygenation in children with heart disease and down syndrome: a multicenter analysis.

Authors:  Punkaj Gupta; Jeffrey M Gossett; Peter T Rycus; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2014-07-31       Impact factor: 1.655

9.  Genomic intensive care: should we perform genome testing in critically ill newborns?

Authors:  Dominic J C Wilkinson; Christopher Barnett; Julian Savulescu; Ainsley J Newson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-09-14       Impact factor: 5.747

10.  Predictors of Length of Hospital Stay After Complete Repair for Tetralogy of Fallot: A Prospective Cohort Study.

Authors:  Laura Mercer-Rosa; Okan U Elci; Grace DeCost; Stacy Woyciechowski; Sharon M Edman; Chitra Ravishankar; Christopher E Mascio; Steven M Kawut; Elizabeth Goldmuntz
Journal:  J Am Heart Assoc       Date:  2018-05-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.